Skip to main content
. 2014 May 19;9(5):e97274. doi: 10.1371/journal.pone.0097274

Table 1. ATP1A3 mutations and clinical features of patients with alternating hemiplegic of childhood.

ID Sex Nucleotide change Amino acid change Father Mother Age at lastassessment Age of onset First symptom Hemiplegic (onset age, duration, frequency) Quadriplegia Abnormal eye movement Dystonia Epilepsy Developmental delay Treatment effect of flunarizine
A02103 F c.410C>A S137Y 3 y9 m 2 m abnormal eye movement 2 m, 1∼3 d, 1∼3 per m + + + +
A01903 F c.1109C>A T370N 11 y11 m 12 m hemiplegia 12 m, 3∼4 d, NA + + + + NA
A05003 M c.2116G>A G706R 8 y 2 m abnormal eye movement 38 m, 1 h∼7 d, 4∼5 per m + + + + +
A03203 M c.2263G>A G755S 1 y4 m 3 m abnormal eye movement 7 m, 2 d, 4∼7 per m + + + +
A06403 M c.2263G>T G755C 4 y1 m 1.5 m abnormal eye movement 10 m, 1∼5 d, 2∼3 per m + + + + Untreated
A02603 M c.2312C>A T771N 6 y2 m 1.5 m abnormal eye movement 7 m, 0.5 h∼2 d, 2∼3 per m + + + +
A00603 M c.2312C>T T771I 14 y3 m 10 m hemiplegia 10 m, 0.1 h∼5 d, 2 per m + + + + NA
A03603 M c.2316C>G S772R 6 y1 m 4 m dystonia 10 m, 3∼4 d, 2∼10 per m + + + +
A01103 F c.2401G>A D801N 5 y6 m 5 m abnormal eye movement 5 m, 4∼5 d, 2∼4 per m + + + +
A02003 F c.2401G>A D801N 3 y6 m 1 m abnormal eye movement 4 m, 2∼3 d, 2 per m + + + + +
A02403 M c.2401G>A D801N 2 y9 m 2 m hemiplegia 2 m, 2∼3 d, 2 per m + + + +
A02203 M c.2401G>A D801N 8 y 4 m hemiplegia 4 m, 2∼4 d, 1∼4 per m + + +
A02503 F c.2401G>A D801N 6 y 7 m hemiplegia 7 m, 3∼5 d, 2 per m + +
A03103 M c.2401G>A D801N 1 y9 m 4 m quadriplegia 4 m, 3 d, 1∼3 per m + + + + +
A04203 F c.2401G>A D801N 3 y7 m 10 m hemiplegia 10 m, 3∼5 d, 3∼10 per m + + + +
A03503 M c.2401G>A D801N 1 y6 m 2.5 m dystonia 6 m, 1∼2 h, 1∼3 per m + + + + +
A02803 M c.2401G>A D801N 2 y5 m 2 m dystonia 2.3 m, 3∼5 d, 1∼2 per m + + + + +
A03703 M c.2401G>A D801N 9 m 2.5 m abnormal eye movement 5.3 m, 6 h∼2 d, 1∼2 per m + + + + +
A03903 M c.2401G>A D801N 11 y11 m 3 m hemiplegia 3 m, 3∼4 d, 8∼10 per m + + + + +
A04603 F c.2401G>A D801N 1 y3 m 3.5 m abnormal eye movement 6 m, 2∼3 d, 3∼4 per m + + + + +
A04803 M c.2401G>A D801N 1 y5 m 3 m abnormal eye movement 6 m, 2∼3 d, 2∼3 per m + + + +
A06103 M c.2401G>A D801N 4 y9 m 1 m abnormal eye movement 1 m, 4∼7 d, 3∼4 per m + + + +
A05603 M c.2405T>C L802P 7 y 14 m abnormal eye movement 14 m, 1 h∼7 d, 3∼4 per m + + + +
A05604 M c.2405T>C L802P 7 y 8 m abnormal eye movement 14 m, 3∼4 d, 3∼4 per m + + + +
A06203 F c.2413G>C D805H 4 y3 m 2 m abnormal eye movement 8 m, 2∼3 d, 3∼10 per m + + + +
A00303 M c.2417T>A M806K NA 7 y6 m 3 m abnormal eye movement 10 m, 1∼7 d, 1 per m + + + +
A05403 M c.2423C>T P808L 1 y9 m 4 m abnormal eye movement 7 m, 2 h∼7 d, 3∼4 per m + + + +
A00403 M c.2429T>A I810N 12 y1 m 1.5 m abnormal eye movement 6 m, 1∼3 d, 1∼10 per m + + + + + +
A00703 M c.2443G>A E815K 6 y6 m 6 m hemiplegia 6 m, 1∼4 d, 1∼4 per m + + + + +
A00503 F c.2443G>A E815K 10 y9 m 6 h abnormal eye movement 7 m, 3∼5 d, 1∼4 per m + + + + NA
A01303 M c.2443G>A E815K NA 4 y7 m 1 m dystonia 4 m,2 d, 3∼4 per m + + +
A01503 F c.2443G>A E815K 3 y10 m 4 m seizure 4 m, 0.5 h∼1 d, 3∼4 per m + + + + + +
A03303 M c.2443G>A E815K 1 y10 m 1 m dystonia 17 m, 2∼3 d, 1 per m + + + + +
A04003 M c.2443G>A E815K 2 y 1 m abnormal eye movement 4.5 m, 2∼5 d, 1∼2 per m + + + +
A02303 M c.2443G>A E815K 4 y3 m 1 m abnormal eye movement 4 m, 2∼3 d, 4 per m + + + + +
A06003 F c.2443G>A E815K 4 y3 m 9 m seizure 9.5 m, 1∼3 d, 3∼10 per m + + + + + +
A06303 M c.2443G>A E815K 4 y11 m 2 m dystonia 7 m, 3∼7 d, 2∼6 per m + + + + + +
A05903 F c.2516T>C L839P 1 y5 m 8 m abnormal eye movement 8 m, 0.5 h∼7 d, 1∼2 per m + + + + +
A02703 F c.2767G>T D923Y 4 y11 m 2 m abnormal eye movement 18 m, 1∼4 d, 1∼2 per m + + + NA
A00103 M c.2839G>A G947R 20 y10 m 2 d abnormal eye movement 36 m, 8∼9 d, 3∼4 per m + + + + +
A00203 F c.2839G>A G947R 10 y6 m 4 m abnormal eye movement 7 m, 0.5 h∼5 d, 2∼3 per m + + +
A01603 M c.2839G>A G947R 6 y 12 m hemiplegia 12 m,7 d, 4 per m + + + +
A03003 F c.2839G>A G947R 2 y5 m 1.5 m abnormal eye movement 4.5 m, 1∼5 d, 4 per m + + + + +
A05303 F c.2839G>A G947R 8 y8 m 4.5 m abnormal eye movement 5 m, 0.5 h∼3 d, 3∼4 per m + + + + +
A02903 F c.2839G>C G947R + 1 y6 m 5 m dystonia 12 m, 1∼2 d, 2∼3 per m + + + + +
A05503 M c.2839G>C G947R 4 y11 m 7 m abnormal eye movement 7 m, 0.5 h∼3 d, 2∼3 per m + + + +
A05803 M 3 y6 m 7 m dystonia 7 m, 1∼5 h, 0∼1 per m + + Untreated
A04503 F 4 y6 m 3.5 m abnormal eye movement 23 m, 0.5∼1 h, 2∼30 per m + + +
A01203 M c.2839G>C G947R 17 y6 m 30 m abnormal eye movement 30 m, 0.5 h∼4 d, 4∼7 per m + + + +
A01403 M c.2309T>G L770R + 9 y5 m 42 m hemiplegia 43 m, 0.1∼0.5 h, 0∼7 per d + + Untreated
A04103 M c.2767G>A D923N 3 y6 m 30 m quadriplegia 30 m, 3 h∼7 d, 4∼7 per m + + + + +
A05203 F c.2677G>A G893R 7 y3 m 24 m hemiplegia 24 m, 0.2 h∼5 d, 2∼3 per m + +

F: female, M: male, y: year, h: hour, d: day, m: month, +: positive, −: negative, NA: not available, Patients A05603 and A05604 were two monozygous twins.